A U.S. judge has declined to approve $94 million in additional legal fees for a group of attorneys who already collected more ...

It looks increasingly clear that for President Trump, tariffs are mainly a convenient means of dominating the news cycle and ...

Amid disturbing revelations that have emerged about the top pick to develop a new $400 million arena for Louisiana State University, stakeholders plan a “due diligence review” to determine the future ...

The Boston Red Sox don't want to overwork their new ace, but for his part, Garrett Crochet will happily go until he can't go anymore. On Sunday, Crochet took t ...

A consortium of investors led by Elon Musk is offering $97.4 billion to buy the nonprofit that controls OpenAI, raising the stakes in his battle with Sam Altman over the company behind ChatGPT ...

Morning Bid: All tariffs, all the timeA look at the day ahead in European and global markets from Wayne Cole. The week started with a now all-too common bang as President Trump used a media scrum ...

Two big defense tech players, Palantir and Anduril, are talking to tech companies including SpaceX, OpenAI, Saronic, and Scale AI about forming a consortium to bid on Pentagon contracts, according ...

Dutch court rejects bid to halt arms exports to Israel as Gaza war rages Court says ‘all claims dismissed’ after rights groups file lawsuit to stop arms sales, citing genocide convention.

Molecular Templates disclaims any intent or obligation to update these forward-looking statements and claims the protection of the Act’s Safe Harbor for forward-looking statements.

Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price Requirements ...

AUSTIN, Texas, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or the “Company”), a clinical-stage biopharmaceutical company focused on the ...